Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	60.24	212.82	132.81
Graham Fair Price	-23.41	0.66	0.86
PEG	22.63	-1.47	-1.90
Price/Book	0.10	-20.32	-20.34
Price/Cash Flow	-112.64	-1701.80	-800.33
Prices/Earnings	72.75	61.74	35.74
Price/Sales	0.00	0.00	0.00
Price/FCF	-112.64	-1701.80	-800.33
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	0.00	0.00	0.00
Operating Margin	0.00	0.00	0.00
ROA	-41.88	< 0.005	< 0.005
ROE	-0.14	-0.08	42.17
ROIC	< 0.005	< 0.005	15.10
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.07	0.08	21.80
EPS QOQ	-0.19	-0.42	-123.28
FCF QOQ	0.12	0.53	347.55
Revenue QOQ	0.00	0.00	0.00
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.00	0.00	0.00
Quick Ratio	0.06	0.05	-20.58
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	-0.48	-0.49	-0.71
Cash	< 0.005	< 0.005	-10.94
Capex	0.00	0.00	0.00
Free Cash Flow	-0.01	< 0.005	52.68
Revenue	0.00	0.00	0.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.16	0.10	-37.70
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.05	-0.07	-41.83
Naive Interpretation	Member

06 - Financial Health · Bad

Rating